drug-induced autoimmune hemolytic anemia
MONDO:0019535Mondo
Findings
No curated finding names drug-induced autoimmune hemolytic anemia yet. Everything below is reference data from Mondo, HPO and GenCC, not evidence about what affects it.
Definition
Drug-induced autoimmune hemolytic anemia is a type of autoimmune hemolytic anemia (AIHA) that occurs as a reaction to therapeutic drugs, and can be due to various mechanisms.
Definition from the Mondo Disease Ontology (MONDO:0019535), read 2026-09-29. CC BY 4.0.
Features
11 features
What the disease is reported to present with, and how often among people who have it — never how often a feature means the disease. HPO, annotations 2026-09-02.
- Autoimmune hemolytic anemiaHPOHP:0001890
- Very frequent (80% to 99% of cases)
- Exertional dyspneaHPOHP:0002875
- Very frequent (80% to 99% of cases)
- FatigueHPOHP:0012378
- Very frequent (80% to 99% of cases)
- HeadacheHPOHP:0002315
- Very frequent (80% to 99% of cases)
- Muscle weaknessHPOHP:0001324
- Very frequent (80% to 99% of cases)
- PallorHPOHP:0000980
- Very frequent (80% to 99% of cases)
- Abnormal urinary colorHPOHP:0012086
- Occasional (5% to 29% of cases)
- Congestive heart failureHPOHP:0001635
- Occasional (5% to 29% of cases)
- Increased total bilirubinHPOHP:0003573
- Occasional (5% to 29% of cases)
- SplenomegalyHPOHP:0001744
- Occasional (5% to 29% of cases)
- TachycardiaHPOHP:0001649
- Occasional (5% to 29% of cases)
Where it sits
- A kind of
Other names
1 name
Resolves to: drug-induced autoimmune hemolytic anemia
- Also called
- drug-induced AIHA